Immune Tolerance: from Gene Expression to Drug Discovery Therapeutic Immunology Group (Prof. H. Waldmann) Therapeutic Antibody Centre (Prof. G. Hale)

Slides:



Advertisements
Similar presentations
Dr.Mohammed Sharique Ahmed Quadri Assistant professor Physiology
Advertisements

José Pedro Lopes Exhausted CD3 CD8 TCR TIM3 1B11 LAG3 Generated in chronic antigen- mediated TCR stimulation. Express inhibitory receptors and lack effector.
Ovarian Cancer: How Basic Research Can Lead to New Opportunities for Early Detection and Treatment.
Immune control of human papillomavirus (HPV) associated anogenital disease and potential for vaccination Peter L. Stern Journal of Clinical Virology, 2005.
Diagnostic Immunology Topic: Immunological Tolerance Objectives: Define Immunological tolerance Define Immunological tolerance Discuss mechanism of tolerance.
Major Histocompability Complex (MHC) Anindyaningrum Chrisant Rystiasih Nadia Karlina *Protein images comparing the MHC I (1hsa) and MHC II (1dlh) molecules.
Schema What is an antigen?
Lecture outline The nomenclature of Immunology Types of immunity (innate and adaptive; active and passive; humoral and cell- mediated) Features of immune.
Lecture outline The nomenclature of Immunology
Lecture outline Signals for T cell activation
Phage Display and its Applications Matt Brown Human Genetics Dr. Nancy Bachman.
1 Characterization, Amplification, Expression Screening of libraries Amplification of DNA (PCR) Analysis of DNA (Sequencing) Chemical Synthesis of DNA.
Introduction to Autoimmunity Alon Monsonego, Ph.D. The department of Microbiology and Immunology Tel:
Signals for T cell activation Costimulation and the B7:CD28 family
Tolerance, autoimmunity and the pathogenesis of immune-mediated inflammatory diseases Abul K. Abbas UCSF.
Immune System Disorders What is an allergy anyway?
Cancer immunology and immunotherapy. First an aside  Oncogenes and tumor suppressor genes.  Definitions anyone?  Oncogene –  Tumor suppressor gene.
Monoclonal antibodies Hybridoma Technique. Monoclonal antibodies (mAb or moAb) Monoclonal antibodies are:  monospecific antibodies that are identical.
MCB 317 Genetics and Genomics MCB 317 Topic 10, part 1 A Story of Transcription.
Cancer Vaccines Medicines that belong to a class of substances known as biological response modifiers. Biological response modifiers stimulate or restore.
BIOMARKER STUDIES IN CLINICAL TRIALS Vicki Seyfert-Margolis, PhD.
18-1 Important terms: Hypersensitivity – immune responses that causes tissue damage Autoimmune disease – immune responses to self-antigens Immunodeficiency.
Finish up array applications Move on to proteomics Protein microarrays.
BIOMARKERS Diagnostics and Prognostics. OMICS Molecular Diagnostics: Promises and Possibilities, p. 12 and 26.
Computational biology of cancer cell pathways Modelling of cancer cell function and response to therapy.
IMMUNE SYSTEM OVERVIEW
1 Dr. Amel Eassawi Dr. Abdelrahman Mustafa. HMIM 224 L3: AUTOTOLERANCE 2.
T-LYMPHOCYTE 1 Lecture 8 Dr. Zahoor. Objectives T-cell Function – Cells mediated immunity Type of T-cells 1. Cytotoxic T-cell – CD8 (Killer T-cell) 2.
Dendritic Cell and its Role in Adaptive Immunity and Cancer Immunotherapy Amna Muhammad Ph. D scholar Biochemistry 1.
Germline-encoded receptors Gene rearranged receptors: TCR/BCR Ags………. Innate immunity Adaptive immunity B/T cells Pattern recognition Epitope recognition.
Concepts of Inflammation and the Immune Response.
Cytokines and Thelper subsets. I. Characteristics of Cytokines (CKs)  CKs are small proteins (
The type of target influence the type of drug Main drugs’ categories –Small molecules –Biologicals (e.g. antibodies, hormones, etc) The drug discovery.
ADAPTIVE IMMUNITY. Adaptive immunity Specific Slow during the primary response, but very fast during the secondary responses memory.
Copyright © 2004 Pearson Education, Inc., publishing as Benjamin Cummings PowerPoint ® Lecture Slide Presentation prepared by Christine L. Case Microbiology.
Chapter 15.  Immunological tolerance is defined as unresponsiveness to an antigen that is induced by previous exposure to that antigen  Antigens that.
Immunological tolerance and immune regulation -- 1
Copyright © 2006 Pearson Education, Inc., publishing as Benjamin Cummings PowerPoint ® Lecture Slide Presentation prepared by Christine L. Case M I C R.
B-cell mediated disease
Immunological tolerance and immune regulation -- 1
HOST DEFENCE AGAINST TUMORS:
Mechanisms of T Cell Tolerance
M1 – Immunology CYTOKINES AND CHEMOKINES March 26, 2009 Ronald B
Chapter 43 The Immune System.
Adaptive Defense System
Unit 3 Autoimmunity Part 1 Introduction
Immunology Lecture 4 Development of B and T lymphocytes
Thymocyte development summary
Concepts of Inflammation and the Immune Response
Chapter 9 T-cell Development
Immunological memory Topics Immune regulation  T cells
Immune System Chapter 14.
Immunological Tolerance
CD4+CD25+ Immunoregulatory T Cells
Tumor Immunology Ali Al Khader, MD Faculty of Medicine
Immunologic Basis of Graft Rejection and Tolerance Following Transplantation of Liver or Other Solid Organs  Alberto Sánchez–Fueyo, Terry B. Strom  Gastroenterology 
Figure 7 Clinical options for HCC therapy
Differentiation and Functions of CD8+ Effector T Cells
Engineering regulatory T cells against factor VIII inhibitors
T cell development.
Chapter 11 T-cell Activation and Differentiation
Exam Three, packet 4 Antigen Recognition
Immune Tolerance Kyeong Cheon Jung Department of Pathology
Diagnostics and Prognostics
Transplantation Immunology
Thomas S. Griffith, Thomas A. Ferguson  Immunity 
Regulatory T Cells and Immune Tolerance
Immunology Dr. Refif S. Al-Shawk
Immunological Tolerance
Multistep Pathogenesis of Autoimmune Disease
Presentation transcript:

Immune Tolerance: from Gene Expression to Drug Discovery Therapeutic Immunology Group (Prof. H. Waldmann) Therapeutic Antibody Centre (Prof. G. Hale)

Immune Tolerance and Therapy Therapy to reverse breakdown of self tolerance in autoimmune diseases Tolerance induction rather than non- specific immunosuppression to avoid rejection of transplanted organs Reversal of acquired tolerance to tumour antigens and latent viral infections

Why Start from Gene Expression? What are the approaches to find new therapeutics: Random screening of chemical libraries in a “surrogate assay” (eg. suppression of antigen specific proliferation in vitro). Look for monoclonal antibodies that modulate a function (eg. same assay). Targeted chemical design/antibodies against specific protein structures. But: How to identify the most relevant/specific target proteins on possibly rare cells? Ideally we want targets expressed ONLY on target cells to avoid potential toxicity against other tissues. An answer: Look for genes that are specifically expressed in the functional cell type of interest – in our example, Th1 but NOT T regulatory (Treg) cells.

Methods for Analysing Gene Expression Analysis of known genes (RT-PCR/Antibodies/Protein Gels): There are >1000 interesting “immunological” genes and probably many more important but unidentified genes. How to choose? Differential Display and Gene Cloning: Clones genes over-expressed in one cell compared to one other, but these may be shared with other cells and you don’t know what you are working with until you have it cloned and sequenced. How to choose? Gene Chips/Arrays Can identify patterns of expression from many (10,000+) genes and multiple samples. Genes must already have been cloned (<1/3 of genome?), it is quick, but not very sensitive (or reliable?), and currently expensive. SAGE (Serial Analysis of Gene Expression) Can identify almost the entire pattern of gene expression (the “transcriptome”) with no a priori knowledge of the gene sequences. Multiple samples are directly comparable as a database. Sensitivity depends on the number of tags sequenced: this can be labour intensive.

CD4 + T cell clones/lines against DBY-E k male antigen CloneSourcePolarised in TypeCytokines R2.2A1(M)xRAG-1 -/- IL-2 Th1IFN-  (graft primed) R2.4A1(M)xRAG-1 -/- IL-4 Th2IL-4, IL-10 (graft primed) Tr1D1 A1(M)xRAG-1 -/- IL-10 Tr1/TregIL-10 (IL-4) (naïve) (  CD3 cloned) A1MPA1(M) naïve Anti-CTLA4 TregIL-10 (IL-4) DBY-E k peptide SKAA1(M) + maleDBY-E k peptide Tskin/TregIL-10 lineskin graft CD4 + sorted IELs

AE = Nla-III TE = BsmF1 SAGE details

Automated DNA Sequencing Machine

Analysis of SAGE data Use SAGEv3.01 software (Velculescu et al) to extract numbers of tags from raw sequence files. Use Access to link tags to known genes, Unigene clusters, and ESTs (from NCBI “reliable tag” list). Use Excel to manipulate data tables and calculate statistics (custom written function for Beysian stats). Use custom written cluster analysis and presentation program (running on Acorn RISC-PC).

DC cluster T cell clone cluster Spleen CD4 cell cluster

Clustered Expression Chart of approx. 300 known genes (CD antigens, cytokines and receptors)

A close up of a Treg cluster of known genes

Real Time PCR Machine

HPRT TM4 Th1 Treg Th1 Treg

Ratio of tolerant to rejecting skin graft expression Quantitative RT-PCR from rejecting, syngeneic and tolerant skin grafts

Fluorescence Activated Cell Scanner

Th1 Th2 Tr1D1 A1MP Tskin Permeabilized Live cells (7AAD neg) Peptide inhibition CD25- CD4+CD25+ Chandra/Ly116 ->

CD103 -> CD4 -> Chandra/Ly116 -> CD103 -> CD25 -> Th1 (R2.2) Th2 (R2.4) Treg(Tr1D1) Tskin(SkA)

The Therapeutic Antibody Centre

Humanized monoclonal antibodies against cell surface molecules expressed by effector but not regulatory T cells

Monoclonal Antibody Production Bioreactor Schematic

Hollow Fibre Bioreactor for Antibody Production

Therapeutic antibody purification

Clinical Trials of Therapeutic Antibody

For more information see the TIG Web site: Or go to the Pathology Web site: And click on “Herman Waldmann”